Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,230 | -6,695 | -3,450 | 31,544 | -1,471 |
| Depreciation Amortization | 10 | 7 | 3 | N/A | N/A |
| Income taxes - deferred | N/A | N/A | N/A | -437 | N/A |
| Accounts payable and accrued liabilities | 377 | -85 | -17 | 84 | 170 |
| Other Working Capital | 477 | -291 | -59 | -26 | -468 |
| Other Operating Activity | 2,380 | 1,750 | 800 | -38,112 | -3,724 |
| Operating Cash Flow | $-6,986 | $-5,314 | $-2,723 | $-6,947 | $-5,493 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 150 | 1,001 | 0 | 5,656 | 5,605 |
| PPE Investments | -79 | -79 | -79 | N/A | N/A |
| Investing Cash Flow | $71 | $922 | $-79 | $5,656 | $5,605 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 379 | 379 | 66 | 524 | 260 |
| Financing Cash Flow | $379 | $379 | $66 | $524 | $260 |
| Beginning Cash Position | 48,588 | 48,588 | 48,588 | 49,355 | 49,355 |
| End Cash Position | 42,052 | 44,575 | 45,852 | 48,588 | 49,727 |
| Net Cash Flow | $-6,536 | $-4,013 | $-2,736 | $-767 | $372 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,986 | -5,314 | -2,723 | -6,947 | -5,493 |
| Capital Expenditure | -79 | -79 | -79 | N/A | N/A |
| Free Cash Flow | -7,065 | -5,393 | -2,802 | -6,947 | -5,493 |